Medtronic 2016 Annual Report Download - page 128
Download and view the complete annual report
Please find page 128 of the 2016 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118 -
119 -
120 -
121 -
122 -
123 -
124 -
125 -
126 -
127 -
128 -
129 -
130 -
131 -
132 -
133 -
134 -
135 -
136 -
137 -
138 -
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
 |
 |
Table of Contents
Medtronic plc
Notes to Consolidated Financial Statements (Continued)
125
across all components. The primary products sold by the Company’s Diabetes Group include those for diabetes management and
the approval process for the Diabetes is similar across all divisions.
Net sales of the Company’s reportable segments include end-customer revenues from the sale of products each reportable segment
develops and manufactures or distributes. Net sales and income before income taxes by reportable segment are as follows:
Fiscal Year
(in millions) 2016 2015 2014
Cardiac and Vascular Group $ 10,196 $ 9,361 $ 8,847
Minimally Invasive Therapies Group 9,563 2,387 —
Restorative Therapies Group 7,210 6,751 6,501
Diabetes Group 1,864 1,762 1,657
Total Net Sales $ 28,833 $ 20,261 $ 17,005
Fiscal Year
(in millions) 2016 2015 2014
Cardiac and Vascular Group $ 3,182 $ 3,140 $ 2,982
Minimally Invasive Therapies Group 1,394 342 —
Restorative Therapies Group 1,976 1,828 1,821
Diabetes Group 543 540 457
Total Reportable Segments’ Income Before Income Taxes 7,095 5,850 5,260
Impact of inventory step-up (226)(623) —
Impact of product technology upgrade commitment — (74) —
Special (gains) charges, net (70) 38 (40)
Restructuring charges, net (1) (299)(252)(88)
Certain litigation charges, net (26)(42)(770)
Acquisition-related items (283)(550)(117)
Interest expense, net (955)(280)(108)
Corporate (900)(581)(432)
Total Income From Operations Before Income Taxes $ 4,336 $ 3,486 $ 3,705
(1) Restructuring charges, net within this table include the impact of amounts recorded within cost of products sold in the consolidated statements
of income.